Effect of WRAD Lens on Axial Growth and Refraction in Low-hyperopic Chinese Children

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age6-9
SponsorHe Eye Hospital

About this trial

Myopia is one of the most common visual impairments worldwide.This not only poses long-term risks to individual health but also imposes significant medical and economic burdens on society. \[6\] Therefore, delaying the onset of myopia and effectively controlling its progression has become an urgent issue that needs to be addressed.In recent years, a new type of highly aspherical lenslet (HAL) has been proposed. Its optical design includes a refractive correction area in the central region and a peripheral annular area. This annular area can form a "myopic defocus zone", increasing the myopic defocus signal around the retina. Studies have confirmed that this design can effectively slow down the progression of myopia in already myopic children. However, it is currently unclear whether this lens has a preventive effect on children who are not yet myopic but have a risk of developing myopia.

Eligibility criteria

Qualifiers

Children aged 6 to 9 with low hyperopia, regardless of gender

The refractive error is between 0 and 2.00D

The best corrected visual acuity of both eyes is ≥ 0.10 LogMAR

The subjects themselves and their guardians voluntarily participated

Disqualifiers

Systemic diseases or eye diseases

Received myopia control treatment through medication or optical

Any situation where participation is deemed unsuitable by the investigator

Trial design

Treatments tested in this trial

  • With-the-Rule Astigmatic Defocus Lens
  • With-the-Rule Astigmatic Defocus Lens (Non-plano)
  • Single Vision

Treatment groups

117 Participants
are divided into 3 treatment groups

Locations

This trial has no locations

Sponsors and collaborators

He Eye Hospital

Lead sponsor

He Eye Specialist Hospital

Collaborator